Two prominent faculty members from the UAB Department of Medicine have been elected to become members of the American Society for Clinical Investigation (ASCI).
A UAB study reconfirms that single-dose azithromycin remains an effective treatment for chlamydia, especially when drug adherence is an issue.
The UAB Undiagnosed Diseases Program, designed to help find answers for rare medical conditions, now has a clinic in Children’s of Alabama.
UAB researchers collaborated on a study showing a blood test for chlamydia might be valuable in screening infertile women for pregnancy outcomes.
In JAMA Viewpoint, Edward W. Hook III, M.D., says doctors and patients must be willing to talk about sex if we are to decrease the nation’s rate of sexually transmitted infections.
Professor Ravi Bhatia, M.D., is the next holder of the Martha Ann and David L. May Endowed Chair in Cancer Research, and Professor Edward W. Hook III, M.D., was chosen to be the inaugural holder of the Cobbs Endowed Professorship in Infectious Diseases.
HIV/AIDS is the leading cause of death worldwide for women ages 15-44 years, and UAB serves as a site for the latest study by the Microbicide Trials Network, which has previously studied this new approach with positive results in other female age groups.
Nicholas Van Wagoner, M.D., Ph.D. recently joined the Department of Medical Student Services as assistant dean for students.
Four projects were awarded through the first School of Medicine AMC21 Reload Multi-Investigator Grants, a broad funding opportunity provided through the Academic Enrichment Fund that enables faculty members to organize and integrate multi-disciplinary teams of accomplished investigators to compete successfully for long-term extramural support.
Michael Saag, M.D., professor of Medicine and director of the UAB Center for AIDS Research, has been named associate dean of Global Health in the School of Medicine.